AP
BIVV

Atwood & Palmer’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Atwood & Palmer’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-350
Closed -$19K – 305
2017
Q4 		$19K Hold
350
– – ﹤0.01% 232
2017
Q3 		$20K Hold
350
– – ﹤0.01% 231
2017
Q2 		$21K Hold
350
– – ﹤0.01% 230
2017
Q1 		$19K Buy
+350
New +$17.2K ﹤0.01% 228

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Atwood & Palmer's BIVV Position: Q1 2018 in Review

Atwood & Palmer sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 350 shares — an estimated $19K sold.

Atwood & Palmer first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $21K in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Atwood & Palmer reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Atwood & Palmer sold 350 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $19K.
  • Atwood & Palmer first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • Atwood & Palmer's Bioverativ Inc. Common Stock position peaked at $21K in Q2 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Atwood & Palmer's 13F filing for Q1 2018, filed 30 Apr 2018.